Position in ACLX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$57,410
New position
Shares Held
500
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#188
of 238 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Strengthening Families & Communities, LLC holds $172,945 across 11 Biotechnology names. ACLX ranks #2 (33.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
1,000 | $67,680 | |
| 2 | ACLX |
Arcellx, Inc.
This page
|
500 | $57,410 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
24 | $18,543 | |
| 4 | VTVT |
vTv Therapeutics Inc.
|
173 | $6,861 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13 | $5,805 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
150 | $4,881 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
79 | $4,462 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
60 | $2,854 |
All Filings in ACLX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $57,410 | 500 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||